Memorial Şişli Hospital
Memorial Şişli Hospital
Turkey, Istanbul
Betul Tavil
29 years of experience
accreditations :
Clinic is certified :
The complex treatment of neuroblastoma in Turkey typically ranges from AUD $39,138 to AUD $58,707. Final costs depend on the surgical complexity, tumor stage, and required chemotherapy cycles. In Australia, similar procedures cost around AUD $670,932 on average. Patients can save approximately 93% by choosing Turkish medical hubs like Istanbul or Antalya. Treatment often includes hospital stays, diagnostic imaging, and dedicated pediatric oncology care.
Bookimed Expert Insight: Choosing a hospital with an integrated Bone Marrow Transplantation Unit offers the best value. Emsey Hospital, for example, operates one of Turkey's largest units with 45 beds. This infrastructure often results in smoother care transitions. Furthermore, hospitals like Medipol Mega University Hospital are frequently ranked best for pediatric cancer care by families. They use high-end technologies like the Da Vinci system and Gamma Knife to treat complex cases.
| Turkey | Thailand | ||
| Complex treatment of neuroblastoma | from AUD $39,138 | from AUD $62,900 | from AUD $34,245 |
Professor Hilmi Apak is a leading specialist at Biruni University Hospital who has published 75 international papers on paediatric blood and cancer disorders.
Dr. Metin Demirkaya is a Professor of Pediatric Oncology at Medicana Bursa Hospital. He specializes in treating childhood cancers, including neuroblastoma, Ewing's sarcoma, and leukemia. Dr. Demirkaya previously practiced at the GATA Pediatric Hematology-Oncology and Bone Marrow Transplantation Centre. He holds a subspecialty in pediatric oncology from Bursa Uludag University.
Dr. Betul Tavil is a professor of pediatric hematology and oncology at Memorial Şişli Hospital. She has successfully treated 500+ children with leukemia. Dr. Tavil is an expert in bone marrow transplantation for complex cases. She manages rare blood disorders, including congenital erythropoietic porphyria and immunodeficiencies. Memorial Şişli Hospital is JCI-accredited and maintains a 90% organ transplant success rate.
Turkish clinics provide comprehensive support for international paediatric cancer patients through dedicated international patient departments. These centres manage logistics for complex neuroblastoma treatments. They offer medical interpreters, airport transfers, and help with long-term family accommodation. This is available in cities like Istanbul and Antalya.
Bookimed Expert Insight: While many centres offer support, Memorial Antalya Hospital stands out. It provides a dedicated 5-star guest house specifically for international families. This is a significant benefit for neuroblastoma cases. They often need multi-week stays for radiotherapy or stem cell transplants.
Patient Consensus: Families find that large hospital groups in Turkey offer well-organised pathways with helpful translators. Established oncology centres provide the necessary aftercare and stable support systems. These are needed for sensitive paediatric treatments.
Turkey hosts JCI-accredited facilities specialising in paediatric oncology and complex neuroblastoma care. Leading centres include Memorial Şişli Hospital, Medipol Mega University Hospital, and Hisar Hospital Intercontinental. These hospitals provide multidisciplinary teams and TrueBeam STx radiotherapy. They also have bone marrow transplant units required for high-risk childhood tumours.
Bookimed Expert Insight: Turkish oncology centres like Memorial Antalya follow strict NCCN and ESMO international guidelines. While basic chemotherapy is common, these major hubs offer rare specialisations. Dr Hilmi Apak at Biruni University Hospital, for example, specialises in haploidentical stem cell transplantation. He also offers CAR T-cell therapy.
Patient Consensus: Large tertiary centres in Turkey are highly praised for managing rare childhood cancers. Families highlight the coordinated care between oncology and surgery. The experience of doctors in major Istanbul hospitals provides immense confidence during complex treatment.
High-risk neuroblastoma survival rates in Turkey have improved significantly. Contemporary specialised centres report 5-year overall survival between 50% and 68%. University hospitals utilise intensive multimodal protocols. These protocols include immunotherapy and stem cell transplantation. They aim to align outcomes with international benchmarks for paediatric oncology care.
Bookimed Expert Insight: Turkish oncology centres offer a massive cost advantage for complex cases. Neuroblastoma treatment starts at $28,000. The A$662,400 Australian average is often prohibitive for uninsured families. However, Medipol Mega University Hospital provides the same multimodal care—surgery, radiotherapy, and stem cell transplant. This comes at a 7793% saving.
Patient Consensus: Success in Turkey relies on finishing the full protocol of chemotherapy, surgery, and immunotherapy. Families appreciate the speed of access and high-quality private hospital care during aggressive treatment cycles.
Neuroblastoma treatment in Turkey uses multi-modal, risk-adapted protocols. These include intensive chemotherapy, surgical resection, and high-dose chemotherapy with autologous stem cell transplantation. Leading JCI-accredited centres like Memorial Şişli and Medipol Mega also provide maintenance therapies. These include anti-GD2 immunotherapy and targeted radiation.
Bookimed Expert Insight: Turkish oncology centres like Medipol Mega often offer haploidentical stem cell transplants. These allow parents to act as donors when a perfect match is unavailable. This capability, combined with all-inclusive pricing from $28,000, makes Turkey a major hub for complex cases. These cases require immediate intervention without donor waitlists.
Patient Consensus: Treatment for high-risk neuroblastoma in Turkey involves a coordinated sequence of surgery, chemotherapy, and immunotherapy rather than a single procedure. Families appreciate having a personal coordinator to help manage these multiple stages and ensure smooth follow-up monitoring after they return home.
Turkish paediatric oncology centres perform comprehensive staging. This includes biopsy, PET-CT or MRI imaging, MIBG scintigraphy, and molecular profiling. These evaluations adhere to TPOG and COG guidelines to map tumour biology and metastatic spread. Specialists use these results to plan risk-adapted therapy before starting complex neuroblastoma treatment.
Bookimed Expert Insight: Turkish centres like Hisar Hospital Intercontinental use 640-slice CT scanners and PET-CT that detect 1-millimetre tumours. This precision is vital for neuroblastoma. Identifying tiny metastatic sites early can significantly change the staging and treatment plan. Centres often bundle these scans into initial diagnostic packages.
Patient Consensus: Diagnostic evaluation is a full staging process rather than a single test. Families found that private Istanbul hospitals coordinate oncology, radiology, and nuclear medicine in one location. This leads to faster results.